For an administration that promises to pull back regulations, CVS Health's (CVS) plan to buy Aetna (AET) for some $69 billion will be a big test for the government, according to TD Ameritrade's chief market analyst JJ Kinahan. 

Kinahan expects this deal to benefit consumers.

More of What's Trending on TheStreet:

 

More from Video

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors

Market of the Week: Euro FX

Market of the Week: Euro FX

Bye, Bye, Bye Sears: The Week Ahead

Bye, Bye, Bye Sears: The Week Ahead

How to Be a Tactical Investor in the Current Market

How to Be a Tactical Investor in the Current Market

Cannabis Legalized in Canada: Keys for Sellers to Unlock Huge Market Opportunity

Cannabis Legalized in Canada: Keys for Sellers to Unlock Huge Market Opportunity